Rikki A. Cannioto

Rikki A. Cannioto

Auto-generated profile, based on publicly available information

Rikki A. Cannioto

Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY 14263, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2021 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
RCRikki A Cannioto
Rikki A Cannioto
AHAlan Hutson
Alan Hutson
SDShruti Dighe
Shruti Dighe
WMWilliam McCann
William McCann
SMSusan McCann
Susan McCann
CAChristine Ambrosone
Christine Ambrosone
Background: Although physical activity has been consistently associated with reduced breast cancer mortality, evidence is largely based on data collected at one occasion. We examined how pre- and postdiagnosis physical activity was associated with survival outcomes in high-risk breast cancer patients. Methods: Included were 1340 patients enrolled in the Diet, Exercise, Lifestyle and Cancer Prognosis (DELCaP) Study, a prospective study of lifestyle and prognosis ancillary to a SWOG clinical trial (S0221). Activity before diagnosis, during treatment, and at 1- and 2-year intervals after enrollment was collected. Patients were categorized according to the Physical Activity Guidelines for Americans as meeting the minimum guidelines (yes/no) and incrementally as inactive, low active, moderately active (meeting the guidelines), or high active. Results: In joint-exposure analyses, patients meeting the guidelines before and 1 year after diagnosis experienced statistically significant reductions in hazards of recurrence (hazard ratio [HR] = 0.59, 95% confidence interval [CI] = 0.42 to 0.82) and mortality (HR = 0.51, 95% CI = 0.34–0.77); associations were stronger at 2-year follow-up for recurrence (HR = 0.45, 95% CI = 0.31 to 0.65) and mortality (HR = 0.32, 95% CI = 0.19 to 0.52). In time-dependent analyses, factoring in activity from all time points, we observed striking associations with mortality for low- (HR = 0.41, 95% CI = 0.24 to 0.68), moderate- (HR = 0.42, 95% CI = 0.23 to 0.76), and high-active patients (HR = 0.31, 95% CI = 0.18 to 0.53). Conclusions: Meeting the minimum guidelines for physical activity both before diagnosis and after treatment appears to be associated with statistically significantly reduced hazards of recurrence and mortality among breast cancer patients. When considering activity from all time points, including during treatment, lower volumes of regular activity were associated with similar overall survival advantages as meeting and exceeding the guidelines.

1 May 2023 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
RCRikki A. Cannioto
Rikki A. Cannioto
KAKristopher M. Attwood
Kristopher M. Attwood
EDEvan W. Davis
Evan W. Davis
LMLucas A. Mendicino
Lucas A. Mendicino
AHAlan Hutson
Alan Hutson
CAChristine B. Ambrosone
Christine B. Ambrosone
The American Institute for Cancer Research (AICR) and the American Cancer Society (ACS) regularly publish cancer prevention recommendations for decreasing the risk of developing cancer.1,2 The most recent recommendations include (1) maintaining a healthy body weight; (2) meeting the physical activity (PA) guidelines; (3) eating a colorful variety of vegetables, fruits, and plenty of whole grains; (4) limiting red and processed meats, fast food, and other highly processed food; (5) avoiding or limiting sugar-sweetened beverages; (6) avoiding or limiting alcohol consumption to 1 drink or fewer per day; and (8) avoiding cigarette smoking.1-4 Despite recommendations to adhere to prevention guidelines after a cancer diagnosis, which lifestyle factors have an impact on cancer outcomes, and whether those factors work together, remains unknown.

28 November 2018 in Cancer Causes & Control
Verified
Journal Article
Open access
PDF file
RCRikki A. Cannioto
Rikki A. Cannioto
SDShruti Dighe
Shruti Dighe
MMMartin C. Mahoney
Martin C. Mahoney
KMKirsten B. Moysich
Kirsten B. Moysich
ASArindam Sen
Arindam Sen
CAChristine Ambrosone
Christine Ambrosone
Purpose The association of recreational physical activity (RPA) with mortality is well established only for breast and colon cancers and few studies have evaluated relationships for exercising before and after diagnosis, across multiple disease sites. We examined the joint associations of pre- and post- diagnosis RPA with mortality in a cohort of 5,807 patients enrolled in the Data Bank and BioRepository at Roswell Park. Methods Patients were classified into one of four activity categories (habitually active, increased activity after diagnosis, decreased activity after diagnosis, habitually inactive). Cox proportional hazards models were used to estimate the associations of activity status with mortality. Results In comparison to patients who were habitually inactive, habitually active patients experienced a 39% decreased hazard of all-cause mortality (HR = 0.61, 95% CI 0.54–0.69) and a 36% decreased hazard of cancer-specific mortality (HR = 0.64, 95% CI 0.56–0.73). Previously inactive patients who began exercising after diagnosis experienced a 28% decreased hazard of all-cause (HR = 0.72, 95% CI 0.59–0.89) and cancer-specific mortality (HR = 0.72, 95% CI 0.57–0.91) in comparison to patients who remained inactive. Patients engaging in 3–4 sessions/week experienced the greatest survival advantages, but 1–2 sessions/week also yielded significant survival advantages in comparison to inactivity. Conclusion Low-to-moderate frequency pre- and post-diagnosis RPA was associated with significantly decreased mortality in patients diagnosed with a variety of malignancies. These observations solidify the clinical and public health importance of the message that some regular activity is better than inactivity, which is particularly encouraging, given that cancer survivors can be overwhelmed by current daily physical activity recommendations.

1 July 2015 in Journal of Lower Genital Tract Disease
Verified
Journal Article
Open access
GFGrace Ma Friel
Grace Ma Friel
CLCici S. Liu
Cici S. Liu
NKNonna V. Kolomeyevskaya
Nonna V. Kolomeyevskaya
SHShalaka S. Hampras
Shalaka S. Hampras
BKBridget Ba Kruszka
Bridget Ba Kruszka
KMKirsten B. Moysich
Kirsten B. Moysich
Objective In this study, we investigated whether regular use of aspirin or acetaminophen was associated with risk of cervical cancer in women treated at an American cancer hospital. Methods This case-control study included 328 patients with cervical cancer and 1,312 controls matched on age and decade enrolled. Controls were women suspected of having but not ultimately diagnosed with a neoplasm. Analgesic use was defined as regular (at least once per week for ≥6 months), frequent (≥7 tablets/week), very long term (≥11 years), or frequent, long term (≥7 tablets per week for ≥5 years). Results Compared to nonusers, frequent aspirin use was associated with decreased odds of cervical cancer (odds ratio, 0.53; 95% confidence interval, 0.29-0.97). A slightly larger association was observed with frequent, long-term use of aspirin (odds ratio, 0.46; 95% confidence interval, 0.22-0.95). Acetaminophen use was not associated with the risk of cervical cancer. Conclusions Our findings suggest that frequent and frequent, long-term use of aspirin is associated with decreased odds of cervical cancer. To our knowledge, this is the first US-based study examining these associations. Given the widespread use of nonsteroidal anti-inflammatory drugs and acetaminophen worldwide, further investigations of the possible role of analgesics in cervical cancer, using a larger sample size with better-defined dosing regimens, are warranted.

28 November 2018 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
JMJennifer M. Mongiovi
Jennifer M. Mongiovi
GZGary R. Zirpoli
Gary R. Zirpoli
RCRikki Cannioto
Rikki Cannioto
LSLara E. Sucheston-Campbell
Lara E. Sucheston-Campbell
DHDawn L. Hershman
Dawn L. Hershman
SMSusan McCann
Susan McCann
The pathophysiology of chemotherapy-induced peripheral neuropathy (CIPN) is not well understood. Currently, dose reduction is the only recommendation for alleviating symptoms, often leading to premature treatment cessation. The primary aim of this analysis was to determine the association between components of diet during taxane treatment for breast cancer and change in CIPN symptoms over treatment. Women with stage II or III invasive breast cancer were enrolled into an ancillary study to the North American Breast Cancer Intergroup phase III trial (S0221) led by the Southwest Oncology Group (SWOG). Questionnaires including a food frequency questionnaire and the Functional Assessment of Cancer Treatment Gynecologic Oncology Group—Neurotoxicity were administered to assess diet and neuropathic conditions at baseline and during chemotherapy. Ordinal regression was used to estimate odds ratios (ORs) for associations between various food groups and change in neuropathy score (< 10%, 10–30%, > 30%) (n = 900). The odds of worse neuropathy decreased by 21% for each increase in tertile of grain consumption (OR = 0.79, 95% CI 0.66–0.94, p = 0.009). We also observed a nominal 19% increase with higher consumption of citrus fruits (OR = 1.19, 95% CI 1.01–1.40, p = 0.05). Distinguishing between those who experienced a moderate and a severe change in neuropathy, we found that citrus fruit and grain consumption may play a role in the severity of symptoms. Since there are no existing dietary recommendations for the management of CIPN, further research is needed to investigate whether there may be certain foods that could worsen or alleviate neuropathy symptoms associated with treatment for breast cancer. ClinicalTrials.gov, NCT03413761 . Registered retrospectively on 29 January 2018.

10 March 2017 in Cancer Causes & Control
Verified
Journal Article
Closed access
PDF file
RCRikki A. Cannioto
Rikki A. Cannioto
BTBritton Trabert
Britton Trabert
EPElizabeth M. Poole
Elizabeth M. Poole
JSJoellen M. Schildkraut
Joellen M. Schildkraut